Inhibition by erlotinib of primary lung adenocarcinoma at an early stage in male mice.

Inhibition by erlotinib of primary lung adenocarcinoma at an early stage in male mice.

Item
http://www.wikidata.org/entity/Q46887943
Signaling of ERBB receptor tyrosine kinases promotes neuroblastoma growth in vitro and in vivoSignificance of the progesterone receptor and epidermal growth factor receptor, but not the estrogen receptor, in chemically induced lung carcinogenesis in female A/J mice.Depletion of tumor-associated macrophages slows the growth of chemically induced mouse lung adenocarcinomasRegulation of cytokine-induced prostanoid and nitric oxide synthesis by extracellular signal–regulated kinase 1/2 in lung epithelial cells.The Kras mutational spectra of chemically induced lung tumors in different inbred mice mimics the spectra of KRAS mutations in adenocarcinomas in smokers versus nonsmokers.Chemoprevention of murine lung cancer by gefitinib in combination with prostacyclin synthase overexpression.Mena invasive (MenaINV) promotes multicellular streaming motility and transendothelial migration in a mouse model of breast cancerErlotinib-induced skin inflammation is IL-1 mediated in KC-Tie2 mice and human skin organ culture.Repurposing FDA-approved drugs as therapeutics to treat Rift Valley fever virus infection.Serum Metabolite Profiles Are Altered by Erlotinib Treatment and the Integrin α1-Null Genotype but Not by Post-Traumatic OsteoarthritisA quantitative volumetric micro-computed tomography method to analyze lung tumors in genetically engineered mouse models.Chemoprevention of lung carcinogenesis in addicted smokers and ex-smokersHonokiol suppresses lung tumorigenesis by targeting EGFR and its downstream effectors.Anticancer kinase inhibitors impair intracellular viral trafficking and exert broad-spectrum antiviral effects.Transcriptional networks in liver and intestinal development.Stimulation of neoplastic mouse lung cell proliferation by alveolar macrophage-derived, insulin-like growth factor-1 can be blocked by inhibiting MEK and PI3K activation.Requirement for MUC5AC in KRAS-dependent lung carcinogenesis
P2860

Inhibition by erlotinib of primary lung adenocarcinoma at an early stage in male mice.

Item
http://www.wikidata.org/entity/Q46887943
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh-hant
name
Inhibition by erlotinib of primary lung adenocarcinoma at an early stage in male mice.
@en
Inhibition by erlotinib of primary lung adenocarcinoma at an early stage in male mice.
@nl
type
label
Inhibition by erlotinib of primary lung adenocarcinoma at an early stage in male mice.
@en
Inhibition by erlotinib of primary lung adenocarcinoma at an early stage in male mice.
@nl
prefLabel
Inhibition by erlotinib of primary lung adenocarcinoma at an early stage in male mice.
@en
Inhibition by erlotinib of primary lung adenocarcinoma at an early stage in male mice.
@nl
P1433
P1476
P2093
P2860
P2888
P304
P31
P356
P433
P478
P50
P577
P698
P921
P356
P1433
P1476
Inhibition by erlotinib of primary lung adenocarcinoma at an early stage in male mice
@en
P2093
P2860
P2888
P304
P31
P356
P433
P478
P50
P577
P698
P921